High-throughput biochemical assays targeting a vital viral protein identified one molecule out of more than 13,000 with promising antiviral activity against SARS-CoV-2.
Vigorous and rapid air exchanges might not always be a good thing when it comes to levels of coronavirus particles in a multiroom building, according to a new modeling study.
Night shift work disrupts the natural 24-hour rhythms in the activity of certain cancer-related genes, making workers more vulnerable to damage to their DNA.
In a first-of-its-kind study, PNNL scientists are learning about how e-cigarettes can lead to changes in proteins at the molecular level that could contribute to disease or other health problems.
Researchers at PNNL have developed a bacteria testing system called OmniScreen that combines biological and synthetic chemistry with machine learning to hunt down pathogens before they strike.
The nation’s ability to test for COVID-19 has expanded, thanks to work at Pacific Northwest National Laboratory, where scientists have established the performance of testing equipment to detect the virus.
Researchers from PNNL have helped colleagues at OHSU identify lipid molecules required for Zika infection in human cells. The specific lipids involved could also be a clue to why the virus primarily infects brain tissue.
Biomedical scientist Brian Thrall co-edited the issue published in the journal NanoImpact. Three of the articles in the issue include multiple PNNL authors.
Researchers from 25 institutions around the country, including PNNL, are working to find out how exercise changes the molecular makeup of our cells to generate health benefits.
To help spur economic development and assist in the battle against COVID-19, PNNL is making available its entire portfolio of patented technologies on a research trial basis—at no cost—through the end of 2020.
PNNL computational biologist Bobbie-Jo Webb-Robertson was recently awarded the “Spirit of nPOD award” to acknowledge her hard work in building, coordinating, and leading the Data Science Working Group.
After 50 years in science and on the eve of retirement, Laboratory Fellow Karin Rodland, a cancer cell biologist at PNNL, is working on experiments she has dreamed about for decades.